Home › Prostate Cancer › Michigan › Ann Arbor
Prostate Cancer clinical trials in Ann Arbor, MI
26 studies for Prostate Cancer are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi away
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
- and 4 more
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
RecruitingObservational study
- University of Michigan Rogel Cancer Center, Ann Arbor
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi away
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
- and 4 more
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RecruitingPhase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi away
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RecruitingPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RecruitingPhase 3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi away
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi away
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- University of Michigan ( Site 0005), Ann Arbor
Precision-Based Genomics in Prostate Cancer
RecruitingObservational study
- University of Michigan, Ann Arbor
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Chelsea Hospital, Chelsea · 15 mi away
- and 2 more
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
RecruitingPhase 1/2
- Research Site, Ann Arbor
Urine Prostate Screening Integrated With MRI for Early Detection of Prostate Cancer, UPRISE Trial
RecruitingHealthy volunteers welcome
- University of Michigan Rogel Cancer Center, Ann Arbor
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Saint Joseph Mercy Chelsea, Chelsea · 15 mi away
- and 1 more
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RecruitingPhase 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Prostate Active Surveillance Study
RecruitingObservational study
- University of Michigan, Ann Arbor
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
RecruitingObservational study
- Rogel Cancer Center, Ann Arbor
EDRN Prostate MRI Biomarker Study
RecruitingObservational study
- University of Michigan, Ann Arbor
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
RecruitingPhase 2
- University of Michigan Health, Ann Arbor
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
RecruitingObservational study
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi away
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
RecruitingPhase 2
- VA Ann Arbor Healthcare System, Ann Arbor
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
RecruitingObservational study
- University of Michigan Rogel Cancer Center, Ann Arbor
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1/2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
RecruitingPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi away
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi away
- and 4 more
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
RecruitingPhase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
RecruitingPhase 2Healthy volunteers welcome
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Ann Arbor
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Ann Arbor
- Cancer (all types)25 studies
- Breast Cancer25 studies
- Lung Cancer23 studies
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer22 studies
- Heart Failure21 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease15 studies
- Pancreatic Cancer14 studies
- Multiple Myeloma13 studies
- Atrial Fibrillation12 studies
- Ovarian Cancer12 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.